Skip to main content
PLOS Global Public Health logoLink to PLOS Global Public Health
. 2025 Apr 29;5(4):e0004325. doi: 10.1371/journal.pgph.0004325

From healthy to unhealthy obesity: A longitudinal study of adults in ELSA-Brasil

Fernanda Duarte Mendes 1, Hully Cantão dos Santos 2, José Geraldo Mill 2, Maria Del Carmen Bisi Molina 2, Maria de Fátima H Sander Diniz 3, Carla Romagnolli Quintino 4, Márcio Sommer Bittencourt 5, Carolina Perim de Faria 1,*
Editor: Julia Robinson6
PMCID: PMC12040175  PMID: 40299945

Abstract

Despite obesity being associated with negative metabolic and cardiovascular outcomes, there is a subgroup of individuals considered healthy. However, there are questions about the stability of the Metabolically Healthy Obesity phenotype. This is a longitudinal study using the ELSA-Brasil cohort, conducted from 2008/10–2017/19 aiming to describe the trajectory of metabolic status of individuals with obesity, as well as the factors associated with the transition into the unhealthy status. Metabolic status was determined using measures of blood pressure, fasting glucose/glycated hemoglobin, triglycerides, and HDL-cholesterol, no previous diagnosis of alteration in any of these parameters nor taking medication to control them. SPSS v.21.0 was used, considering p < 0.05 as significant. The sample consisted of 190 Metabolically Healthy Individuals with Obesity at baseline, of whom 75.8% transitioned to Metabolically Unhealthy status on the third wave of the study. The baseline data indicates that 8.6% of individuals with obesity were metabolically healthy, and in the follow-up, the prevalence was 5.5%. Alcohol use was a risk factor for metabolic status transition [RR: 1.359 (95%CI: 1.005–1.838)]. Also, each 1 cm increase in waist circumference contributed to a 1% increase in the risk of transitioning from healthy to unhealthy metabolic status [RR: 1.011 (95%CI: 1.004–1.018)]. Being a metabolically healthy individual with obesity is a transient state and alcohol consumption as well as increases in waist circumference are risk factors for the metabolic transition.

Introduction

The prevalence of obesity has been rising worldwide, and because of this epidemic, there has also been an increase in the incidence of noncommunicable chronic diseases [13]. This occurs due to the chronic inflammatory state caused by obesity, as well as the influence that excess fat has on various unfavorable cardiometabolic outcomes [3,4]. However, the literature shows that not all individuals with obesity exhibit the same cardiometabolic risk [5,6]. It is believed that there is a subset of individuals with obesity who can be considered metabolically healthy [5,7].

The phenotype of metabolically healthy obesity (MHO) refers to individuals with obesity who do not show alterations in cardiometabolic markers [5]. These individuals have normal values of blood pressure (BP), fasting glucose, HDL cholesterol, triglycerides (TG), waist circumference (WC), and other measures [1,8,9]. Additionally, they do not use medications for dyslipidemia, hypertension, or diabetes, and have no presence of cardiovascular disease [8,9]. Although this topic has recently been more explored, our understanding of MHO is still limited [10]. The scientific literature is still divided on the topic. While some authors suggest that MHO exists and can be considered a protective state against cardiometabolic alterations and mortality, others argue that MHO is merely a stage of metabolic balance, marking the transition between a healthy state and the classification of metabolically unhealthy obesity (MUO) [1,2].

Starting from the assertion that MHO is a transient state, questions arise about whether it is indeed an unstable condition, and which variables might be associated with the transition from MHO to MUO [11]. The literature indicates sex and age as related variables, sedentary behaviour, smoking, and continuous alcohol use also appear to be risk factors for transitioning to an unhealthy status [12,13]. Additionally, dietary intake, particularly the consumption of ultraprocessed foods, has been associated with an unfavorable metabolic profile [14].

Thus, our objective is to assess whether metabolically healthy obesity is a transient state, as well as to identify the factors that influence the transition to metabolically unhealthy obesity. The study analyzes the trajectory of metabolic status and associated variables from baseline and the third wave of follow-up in the ELSA-Brasil cohort.

Methods

This is a longitudinal study conducted using the baseline or wave 1 (W1) (August 2nd2008- December 17th2010) and the third wave (W3) (April 2nd2017- May 31st2019) of the Brazilian Longitudinal Study of Adult Health (ELSA-Brasil). ELSA-Brasil is a multicenter cohort study of 15,105 adults (35–74 years old at baseline, 2008–2010), all active or retired civil servants of six Brazilian public universities and one research institution. Detailed information about the cohort has been published elsewhere [15].

The sample is composed of all participants classified as MHO at baseline. Those who did not have data regarding the MHO diagnostic variables at baseline and follow-up were excluded from this analysis. Individuals were classified as having MHO based on the criteria proposed by Quintino [16]. According to these criteria, individuals are considered healthy if they do not meet any of the conditions listed in Table 1.

Table 1. Criteria for evaluating metabolically healthy obesity (MHO) according to the cutoff points proposed by Quintino [2018].

CRITERIA
Blood pressure abnormalities A self-reported medical diagnosis of arterial hypertension OR Antihypertensive drug use OR Systolic blood pressure ≥ 130 mmHg OR Diastolic blood pressure ≥ 85 mmHg
Glucose metabolism abnormalities A self-reported medical diagnosis of diabetes mellitus OR Antidiabetic drugs use OR Fasting blood glucose ≥ 100mg/dL OR Glycated hemoglobin ≥ 6,5%
Lipids metabolism abnormalities A self-reported medical diagnosis of hypertriglyceridemia OR Triglycerides ≥ 150 mg/dL OR use of statins
A self-reported medical diagnosis of low HDL OR HDL <40 mg/dL (men) or <50 mg/dL (women) OR use of statins

Note: HDL: High-density lipoprotein.

Body weight, height, and waist circumference (WC) were collected according to the methods proposed by Lohman et al. [17]. BMI was calculated and categorized according to WHO [18]: “Underweight” (BMI < 18.5 kg/m2), “Normal weight” (BMI 18.5 - 24.9 kg/m2), “Overweight” (BMI 25.0 - 29.9 kg/m2), and “Obesity” (BMI ≥ 30.0 kg/m2), considering for the study those individuals who were in the “obesity” category [15].

Blood collection was carried out after an average fast of 12 hours, with details described by Fedelli et al. (2013) [19].

Blood pressure (BP) was measured while subjects were still fasting, in a sitting position after a minimum of 5 min resting period in the left arm. Three measurements were obtained at one-minute intervals and the average of the last two measurements was considered as the casual BP.

All medications used regularly were obtained during an interview on the same day of the exams and they were coded according to the Anatomical Therapeutic Chemical classification. The presence of the following classes of medications was considered: antihypertensives, antidiabetic agents, and fibrates, niacins, and statins. The use of each of the registered drugs was expressed as a binary variable (yes/no) [15].

The assessment of individuals’ habitual food consumption was conducted using the Food Frequency Questionnaire (FFQ). This is a semi-quantitative instrument designed to estimate dietary intake over the past twelve months. The FFQ applied was structured with food items/preparations, portion sizes, and consumption frequencies. It offers eight response options, ranging from “More than 3 times/day” to “Never/Almost Never.” Seasonal consumption was also considered for individuals who reported consuming a specific food item only during a particular time of year or season.

At baseline, the FFQ contained 114 food items and was validated for the Brazilian population [20]. In wave 3, a shortened version of the FFQ was used, reducing the number of items from 114 to 76, a 33% reduction. However, the shortened version maintained good capacity to measure energy and nutrients and it was also validated for the population [21].

The Nutrition Data System for Research software was used to analyze the consumption data reported in the FFQ. Extreme consumption values (above the 99th percentile) were replaced with the exact value of the 99th percentile. Additionally, when participants voluntarily reported seasonal consumption of a specific item, the total daily intake of that food was multiplied by 0.25 [20,21].

For this study, the classification of foods according to the degree of processing was adopted. The study followed the NOVA classification proposed by Monteiro et al. (2016) [22] which separates foods into four groups: unprocessed or minimally processed foods, processed culinary ingredients (MPF), processed foods (PF), and ultra-processed foods (UPF) [14]. The next step estimated the contribution in calories and grams of each food category and its proportion considering daily food/calorie intake. After an initial analysis, the percentual contribution of each food category was chosen to be addressed in grams, as there was no significant difference between the two options and the variable in grams allows the inclusion of light/diet beverages in the study. Food intake was analyzed longitudinally (dynamic model), using average consumption data from baseline and follow-up. For the calculation of the variable, the contribution in grams of each food group was used, as well as the percentage contribution of each group to the diet. This calculation was made based on the dietary consumption data from baseline and wave 3. To generate the dynamic variable, the average of the values found at both time points was calculated. Furthermore, the variable “dietary change” was utilized to assess the impact of a potential shift in dietary habits while maintaining metabolic status, and to justify the findings regarding the relationship between dietary consumption and metabolic status. The International Physical Activity Questionnaire (IPAQ) long version, validated for Brazil by Matsudo et al. [23] was used for the measurement of physical activity (PA) in minutes/week; it was done by multiplying the weekly frequency by the duration of each activity performed. The classification proposed by the WHO for insufficient, moderate, and vigorous activity was used, which recommends at least 150 minutes of moderate PA per week, or 75 minutes or more of vigorous PA [24,25].

Sociodemographic variables were collected by a standardized questionnaire administered in an interview. Sex was categorized as male and female and age into quartiles. Race/skin color was categorized as white, black, brown, and yellow or indigenous. Education was categorized as primary education, secondary education, and higher education. The occupational category variable classifies individuals according to the type of work and is categorized as higher, middle, and manual. Per capita family income was calculated based on the total net income of the family in Brazilian reais over the previous three months, divided by the number of people dependent on that income. The smoking variable was categorized as “former” “current,” or “never” smoked. Alcohol consumption was measured using an Alcohol Consumption questionnaire, structured with close-ended questions, based on the National Center for Health Statistics questionnaire (1994) [26].

All variables are presented as proportions, means, and standard deviation (SD), or medians. The Kolmogorov-Smirnov test was used to assess the normality of data. For continuous variables, the student’s t-test for independent samples and the Mann-Whitney test were used. For categorical variables, the chi-square test and Fisher’s exact test were used.

The metabolic status transition between baseline and follow-up was dichotomized as No and Yes, where “No” indicates individuals who remained healthy in both study segments (baseline and follow-up), and “Yes” includes those who changed status from baseline to follow-up. Relative risk measures, both crude and adjusted, with their respective 95% confidence intervals were obtained through Poisson regression models with robust variance. All variables with p < 0.20 in the bivariate analysis were considered potential predictors of the metabolic status transition and inserted in the multivariate models. SPSS for Windows version 21 was used for statistical analyses adopting p < 0.05 as significant.

Sensitivity analyses were conducted to ensure greater precision of the findings. It was carried out in relation to the MHO diagnostic criterion, maintenance of bariatric participants, classification of foods items and the approach used in the analysis (grams or kcal) as well as assessing the diet at baseline, at follow-up, and the average of both and the information about diet changes over the previous 6 months and finally in relation to the variables of physical activity (PA). Final stage of quality control was an analysis of losses aiming to explore possible differences between the sample selected for the study and study losses and exclusions.

Ethical considerations

The ELSA-Brasil protocol was approved by the National Ethics Committee under the registration number 140/08 and by the ethics committees of each participating CI, with the following registration numbers: 669/06 (USP), 343/06 (FIOCRUZ), 041/06 (UFES), 186/06 (UFMG), 194/06 (UFRGS), 027/06 (UFBA). As an inclusion criterion for the study, all those who wished to participate in the research read and signed the Informed Consent Form (ICF). The use of the data from this research was only possible after prior approval from the ELSA-Brasil’s Project Publications Committee.

Results

From the 15,105 participants included in the baseline of the ELSA-Brasil study. The average follow-up time was 7.7 years (minimum: 7 and maximum: 9). 3,540 of the participants (23,4%) were classified as individuals with obesity, having a mean BMI of 33.6 (SD) kg/m2. 3,428 (96.8%) had all data necessary to obtain the metabolic classification and 294 (8.6%) were classified as presenting MHO. Fig 1 shows the flowchart, indicating the metabolic status of the participants at each of the two waves and the inclusion flow in the study from baseline. At follow-up, of the 3,084 individuals with obesity evaluated, 169 (5.5%) were metabolically healthy. From those 294 MHO on baseline, 104 were lost due to follow-up or missing key variables, of these, 63.5% did not have the necessary data for the diagnosis of MHO, 30.7% refused to participate in the follow-up, 4.8% passed away, and 1% could not be located, resulting on a sample of 190 individuals that were included.

Fig 1. Sample selection flowchart.

Fig 1

Note: Number indicates the number of subjects and in parenthesis percentage.

Table 2 shows that, at baseline, significant differences were found between groups concerning age (p < 0.001) and sex (p < 0.001), with women comprising the majority of those classified as MHO (78.6%). Married individuals were more prevalent among the unhealthy status (p = 0.011), while those with higher education were more likely to be in the MHO group (52.4%, p < 0.001). Manual occupation was more common among the MUO participants (p = 0.007), and non-smoking was predominant in the MHO group (64.6%, p = 0.001). Bariatric surgery was more prevalent in the MHO group (6.2%) compared to the MUO group (1.2%, p < 0.001). Healthier individuals had lower BMI and waist circumference (WC) (p < 0.001 for all). Processed food consumption was higher among MHO individuals (p = 0.002).

Table 2. Pointwise characterization of metabolic status according to sociodemographic, lifestyle, anthropometric, and dietary intake variables at baseline and follow-up of the ELSA-Brasil study.

Variables Baseline
MHO MUO p-Value
294 (8,6) 3.134 (91,4)
Age p < 0,001*
Quartile 1(≤ 46.0 years) 132 (44,9) 765 (24,4)
Quartile 2(47.0–52.0 years) 83 (28,2) 783 (25,0)
Quartile 3(53.0–59.0 years) 49 (16,7) 849 (27,1)
Quartile 4(≥ 60.0 years) 30 (10,2) 737 (23,5)
Gender p < 0,001*
Male 63 (21,4) 1.344 (42,9)
Female 231 (78,6) 1.790 (57,1)
Race/ethnicity 0,242
Black 71 (24,4) 649 (21,0)
Brown 84 (28,9) 874 (28,2)
White 132 (45,4) 1.482 (47,9)
Asian/Indigenous 4 (1,4) 91 (2,9)
Marital status 0,011
Married/Common-law marriage 175 (59,5) 2.135 (68,1)
Separated/Divorced/Widowed 82 (27,9) 684 (21,8)
Single 37 (12,6) 315 (10,1)
Education p < 0,001*
Primary education 16 (5,4) 522 (16,7)
Secondary education 124 (42,2) 1.219 (38,9)
Higher education 154 (52,4) 1.393 (44,4)
Occupational category 0,007
Higher 95 (32,8) 980 (31,8)
Middle 156 (53,8) 1.452 (47,2)
Manual 39 (13,4) 646 (21,0)
Monthly per capita Income (BR reais) 1.680,9 ± 1.425,6 1.563,9 ± 1.330,7 0,116
Smoking habit 0,001
Never smoked 190 (64,6) 1.691 (54,0)
Former smoker 73 (24,8) 1.102 (35,2)
Current smoker 31 (10,5) 341 (10,9)
Alcohol use 0,690
Non-user 105 (35,7) 1.082 (34,6)
User 189 (64,3) 2.049 (65,4)
Leisure-time PA 0,347
Weak 235 (81,6) 2.576 (83,1)
Moderate 37 (12,8) 405 (13,1)
Strong 16 (5,6) 118 (3,8)
Bariatric surgery p < 0,001*
No 273 (93,8) 3.068 (98,8)
Yes 18 (6,2) 38 (1,2)
BMI (kg/m2) 32,9 ± 2,9 33,8 ± 3,6 p < 0,001*
WC (cm) 100,5 ± 8,6 106,9 ± 10,1 p < 0,001*
% of grams of MPF W1 and W3 76,2 ± 9,5 76,9 ± 10,5 0,157
% of grams of PF W1 and W3 9,1 ± 6,2 9,9 ± 7,6 0,710
% of grams of UPF W1 and W3 14,6 ± 7,8 13,2 ± 8,0 0,002

Note: PA: physical activity; BMI: Body Mass Index; WC: waist circumference; MPF: minimally processed food; PF: processed food; UPF: ultra-processed food. W1: Wave 1or baseline; W3: Wave 3.Variables were expressed as mean ± standard deviation or n (%). Student’s t-test and Mann-Whitney test were used.

In Table 3, the characterization of the metabolic status transition is described according to sociodemographic, lifestyle, anthropometric, and dietary consumption variables after an average 7.7 years of follow-up. When analyzing the status transition in follow-up, out of the 190 individuals classified as MHO at baseline and with all data in follow-up, 75.8% experienced status transition, moving from MHO to MUO. When comparing the group that transitioned from healthy to unhealthy status, statistically significant differences are noted in alcohol use (p = 0.007), with alcohol consumers predominantly allocated in the “Yes” transition group (63.9%). Additionally, statistically significant data is observed for the variables of WC and waist-to-hip ratio, with lower mean values observed in individuals classified as “No,” who did not experience a status transition (p = 0.002 and p = 0.001, respectively).

Table 3. Characterization of metabolic status transition according to sociodemographic, lifestyle, anthropometric, and dietary consumption variables after an average 7.7 years of follow-up in the ELSA-Brasil study.

Metabolic status transition between baseline and follow-up
No Yes p-Value
46 (24,2) 144 (75,8)
Age 0,928
Quartile 1(≤ 53.0 years) 14 (30,4) 39 (27,1)
Quartile 2(54.0–58.0 years) 10 (21,7) 35 (24,3)
Quartile 3(59.0–65.0 years) 11 (23,9) 39 (27,1)
Quartile 4(≥ 66.0 years) 11 (23,9) 31 (21,5)
Gender 0,167
Male 7 (15,2) 36 (25,0)
Female 39 (84,8) 108 (75,0)
Race/ethnicity 0,558
Black 10 (21,7) 32 (22,5)
Brown 18 (39,1) 42 (29,6)
White 18 (39,1) 66 (46,5)
Asian/Indigenous 0 (0,0) 2 (1,4)
Marital status 0,304
Married/Common-law marriage 23 (50,0) 90 (62,5)
Separated/Divorced/Widowed 14 (30,4) 35 (24,3)
Single 9 (19,6) 19 (13,2)
Education 0,643
Primary education 1 (2,2) 8 (5,6)
Secondary education 17 (37,0) 51 (35,4)
Higher education 28 (60,9) 85 (59,0)
Occupational category 0,530
Higher 11 (25,0) 48 (33,8)
Middle 27 (61,4) 75 (52,8)
Manual 6 (13,6) 19 (13,4)
Monthly per capita Income (BR reais) 3.941,2 ± 3.342,6 3.449,4 ± 2.707,9 0,427
Smoking habit 0,689
Never smoked 30 (65,2) 86 (60,1)
Former smoker 14 (30,4) 46 (32,2)
Current smoker 2 (4,33,4) 11 (7,7)
Alcohol use 0,007
Non-user 27 (58,7) 52 (36,1)
User 19 (41,3) 92 (63,9)
Leisure-time PA 0,481
Weak 34 (73,9) 111 (77,1)
Moderate 10 (21,7) 22 (15,3)
Strong 2 (4,3) 11 (7,6)
Bariatric surgery 0,231
No 42 (91,3) 138 (95,8)
Yes 4 (8,7) 6 (4,2)
BMI (kg/m2) 34,3 ± 2,5 35,0 ± 3,5 0,332
WC (cm) 103,9 ± 9,0 109,7 ± 10,6 0,002
Dietary change 0,339
No 23 (50,0) 83 (58,0)
Yes 23 (50,0) 60 (42,0)
% of grams of MPF W1 and W3 78,1 ± 7,5 75,5 ± 10,0 0,123
% of grams of PF W1 and W3 9,0 ± 5,7 9,4 ± 6,1 0,785
% of grams of UPF W1 and W3 12,9 ± 6,1 15,1 ± 8,2 0,108

Note: PA: physical activity; BMI: Body Mass Index; WC: waist circumference; MPF: minimally processed food; PF: processed food; UPF: ultra-processed food.W1: Wave 1or baseline; W3: Wave 3. Variables were expressed as mean ± standard deviation or n (%). Student’s t-test and Mann-Whitney test were used.

The variables from Table 3 with p < 0.20 were included as potential predictors of metabolic status transition risk. Thus, the model included sex (p = 0.167), alcohol use (p = 0.007), waist circumference (p = 0.002), % of AMP (p = 0.123), and % of AUP (p = 0.108). The crude model refers to the risk analysis between each described variable and the metabolic status transition variable. In the adjusted model, all variables from the table were included in the regression and were related to the metabolic status transition variable.

The relative risk analysis among the variables is described in Table 4. After adjustments, individuals who consume alcohol showed a greater risk for metabolic status transition [RR: 1.238 (95% CI: 1.004–1.499)]. Additionally, a 1 cm increase in WC contributes to a 1% increase in the risk of changing from healthy to unhealthy metabolic status [RR: 1.011 (95% CI: 1.004–1.018)].

Table 4. Relative Risk and Confidence Interval for the Transition of Metabolic Status in Follow-up and Sociodemographic, Lifestyle, Anthropometric, and Dietary Consumption Variables from ELSA-Brasil.

Variables Raw model Adjusted Model
RR (95% CI) RR (95% CI)
Gender
Female Ref Ref
Male 1,140 (0,967–1,342) 1,010 (0,854 -1,194)
Alcohol use
Non-user Ref Ref
User 1,259 (1,0521,507) 1,238 (1,023–1,499)
WC (cm) 1,012 (1,005–1,019) 1,011 (1,004–1,018)
% of grams of MPF W1 and W3 0,993 (0,986–1,000) 1,006 (0,994–1,018)
% of grams of UPF W1 and W3 1,008 (1,000–1,017) 1,012 (0,998–1,026)

Note: RR: Relative Risk; CI: Confidence Interval; BMI: Body Mass Index; WC: Waist Circumference; MPF W1 and W3: average percentage of minimally processed foods at wave 1 and 3.UPF W1 and W3: average percentage of ultra-processed foods at wave 1 and 3. Poisson regression–robust estimator. Model I: Adjusted for all included variables.

Furthermore, sensitivity analyses were conducted regarding a few variables used. Regarding physical activity (PA), in addition to the categorical variable used in the study, we also tested PA as a continuous variable considering the duration of strong, weak, and moderate PA per week, but none showed statistically significant results. Also, as a measure of quality control, sensitivity analysis was performed by three independent researchers (FDM; CPF; HCS) to clarify doubts regarding the classification of certain foods as processed or ultra-processed: feijoada, popcorn, stroganoff, yakisoba, coffee with sweetener, natural juice with sweetener, and tea/mate with sweetener. There was no statistical difference regarding the two ways of classifying the foods; therefore, it was decided to display the results according to the classification previously described in the methodology and used in other ELSA-Brasil’s publications.

Regarding the sensitivity analysis, the variables that showed significant differences in the methods of Wildman et al. and Quintino were similar, so we opted to use the stricter criteria proposed by the later in this study [9,16]. Similarly, the data analysis with and without the individuals who underwent bariatric surgery was comparable, so we chose to include them in the study. According to the dietary assessment, there was no difference presented between the approach using grams or calories, so we used grams in this study in order to keep diet/light beverages in the analysis. Additionally, there was no statistical difference regarding the reclassification of doubtful foods in the NOVA system. The continuous physical activity variables also did not show statistical differences between the groups, so we used the categorical variable in this work. The diet change variable had a p-value of 0.339, indicating that this is not a factor influencing the findings of the study.

Also, the final regression was tested using the follow up duration as a potential confounder and it yielded extremely similar results, demonstration no significant effect on the risk factors identified or their measures of association. Finally, the analysis of losses was conducted, and there was no statistical difference in any of the variables, thus concluding that the losses were non-differential.

Discussion

Our work indicates that most MHO individuals evolve into MUO after an average 7.7 years, reinforcing that MHO is a transitional state. Furthermore, alcohol appears to stimulate the process of metabolic status transition. Moreover, an increase in waist circumference also is a significant predictor for the risk of transitioning from a healthy metabolic status to an unhealthy one.

The data shows that 75.8% of the MHO individuals at baseline experienced a transition in metabolic status, moving from healthy to unhealthy after follow-up. Similar findings were reported by researchers who used data from the Framingham Heart Study, where 71.3% of the 230 MHO individuals transitioned to MUO after nearly 13 years of monitoring [1]. Furthermore, a study conducted at a private hospital in São Paulo demonstrated that out of the 812 participants with MHO at the beginning of the study, 35.3% underwent a transition in status after 3.5 years of follow-up, becoming metabolically unhealthy individuals with obesity (2). The work of Palatini and colleagues, conducted with a population from Italy (n = 1,210), indicated that the MHO state is an unstable condition, as after 7.5 years of follow-up, 59.3% of individuals with MHO transitioned to an unhealthy status [5].

Data from a literature review and a study conducted in China with 458,246 adults showed that potential mediators of the transition in metabolic status include body fat distribution, with the accumulation of visceral fat and impaired adipose tissue function, resulting in hypertrophy and impaired lipid metabolism, as well as inflammation and adipogenesis [7,27]. These changes contribute to a higher burden of reactive oxygen species, which leads to increased lipid peroxidation, decreased adiponectin, damage to adipocyte DNA, and lipogenesis [27,28]. Although the MHO condition is considered relatively healthy, some authors argue that it cannot be regarded as a state of total health, as reactive oxygen species produced in obesity cause chronic damage to lipoproteins [28]. Thus, when a cardiometabolic alteration described in the MHO diagnostic criteria occurs, the transition of metabolic status happens [4].

It is believed that metabolic health plays a fundamental role in predicting adverse health risks over the years [4]. Thus, those who undergo a transition in metabolic status may develop changes in glycemic and lipid profiles, as well as blood pressure, which can result in the incidence of type II diabetes, hypertension, dyslipidemias, and culminate in other associated diseases such as cardiovascular diseases, chronic kidney disease, and cancer [11,13]. Concurrently, after transitioning to an unhealthy status, the individual should exhibit a higher risk of all-cause mortality [29].

It was noted, then, that individuals who are alcohol consumers are at greater risk for the transition in metabolic status. Corroborating this finding, a study conducted on 3,669 Taiwanese military personnel showed that among the MHO individuals, 55.8% (n = 181) did not consume alcohol, compared to 53.2% (n = 647) of the MUO individuals [10]. Furthermore, a study conducted amid 728 people with alcohol use disorders in Spain showed that the prevalence of metabolic syndrome was 13.9% (n = 101). Among these patients, 86.9% were individuals with obesity, 27.7% determined as having diabetes, and 78.2% had elevated fasting glucose levels. Additionally, 70.3% had high blood pressure, 15.3% had a history of cardiovascular disease, 80.2% had elevated triglyceride levels, and 67.3% had low HDL cholesterol levels [30].

It is known that excessive alcohol consumption is toxic to all tissues and bodily systems. A study conducted in Russia with 2,381 adults showed that alcohol consumption influences energy intake by increasing appetite and affecting satiety, thus promoting weight gain [31]. Furthermore, through its impact on the sympathetic nervous system and the release of nitric oxide, excessive alcohol consumption impairs endothelial vasodilatation, leading to endothelial dysfunction and cell apoptosis, contributing to the development of hypertension [32]. Moreover, it is suggested that the effects of alcohol on cardiometabolic alterations are influenced by its impact on WC [31,32]. Contributing to this statement, a study conducted with 2,629 adults from Russia classified individuals based on alcohol consumption into four groups: non-drinkers, non-problematic drinkers, hazardous drinkers, and harmful drinkers, with the first group having zero alcohol consumption and the last group exhibiting the highest consumption. The study showed that hazardous-drinking men had a larger WC of 6.11 cm than non-problematic drinkers, whereas non-problematic drinking women had a larger WC of 2.92 cm when compared to non-drinkers [31].

WC by itself was shown to be associated with a change in metabolic status, as our study confirmed that a 1 cm increase in WC increases the risk of transitioning from MHO to MUO by 1%. Reinforcing this statement, the work of Hamer and colleagues does not attribute the transition of status to lifestyle habits such as physical activity and diet, but rather to increases in waist circumference, which possibly reflects changes in visceral adiposity [8]. Furthermore, a study conducted with 13,525 Chinese adults showed that individuals classified as metabolically healthy had a smaller WC compared to those classified as unhealthy [33].

It is believed that the relationship between WC and metabolic status is justified by its impact on the components of metabolic syndrome. Excess abdominal adiposity leads to overstimulation of leptin secretion and increases sodium absorption after activation of the renin-angiotensin-aldosterone system, resulting in increased blood pressure [34]. Furthermore, the chronic state of inflammation, characterized by increased levels of C-reactive protein, inflammatory cytokines, resistin, leptin, and adiponectin, affects insulin resistance, leading to the exhaustion of pancreatic beta cells and impairing the maintenance of normoglycemia [10,34].

Sex did not demonstrate being associated with the risk of metabolic status transition. A similar result was found by Palatini and colleagues, indicating that sex was not a significant predictor for metabolic status transition [5]. Another study conducted with participants from the United States carried out a 30-year follow-up to observe the transition of metabolic status and stated that women move in and out of the MHO classification over the years, while men do not; after transitioning from MHO to MUO status, they generally remain in the unhealthy state [6].

Regarding eating habits, two longitudinal studies—one conducted in Spain with 5,373 older adults and another in Brazil with 8,065 adults and older adults—showed an association between diet, particularly its (higher) content of ultraprocessed foods, and components of metabolic syndrome [14,35]. However, in our study the consumption of MP and UP did not appear to be associated with the risk of metabolic status transition. Corroborating this finding, a study conducted with 160 workers in Brazil showed that the NOVA classification is not associated with metabolic status [3]. The dietary intake of ELSA participants shows a higher percentage of MP consumption in both groups, MHO and MUO (78.1% and 75.5%, respectively), with no statistical difference between them. This value is higher than the average value for the Brazilian population, which consumes an average of 53.4% of natural and minimally processed foods [36]. It seems that the individuals analyzed in ELSA have better dietary habits than the whole of the Brazilian population, which may have made it difficult to find any association between diet and metabolic status.

It is worth noting that the study has some limitations. The lack of consensus on the criterion for evaluating MHO hinders comparison with other studies. Additionally, the ELSA-Brasil sample is not representative of the Brazilian population. Furthermore, participants’ dietary patterns are similar, which might influence the obtained results; not to mention that the variable is subject to participant memory and response bias, which can underestimate or overestimate consumption. However, the study’s strengths are highlighted: the longitudinal design allows establishing a cause-and-effect relationship between the analyzed variables. The criterion used to assess WHO does not consider any cardiometabolic alterations, ensuring that individuals are indeed healthy at the time of diagnosis. Despite the self-reported consumption data, the questionnaires were validated for the Brazilian population, and the interviewers were previously trained, ensuring the internal validity of the data.

Conclusion

The metabolic health of most individuals with obesity appears to be a dynamic state, as evidenced by the significant proportion of participants classified as metabolically healthy obese (MHO) who transitioned to the metabolically unhealthy obese (MUO) state during the follow-up period. Our findings align with previous research, emphasizing the vulnerability of the MHO phenotype to metabolic decline, as only a small minority were able to maintain metabolic health over the years.

The analysis reveals that visceral fat accumulation is a key factor driving the transition from MHO to MUO, with alcohol consumption also contributing to this metabolic decline. These insights highlight critical opportunities for interventions aimed at preventing or delaying this transition, such as promoting the reduction of visceral fat and encouraging healthier lifestyle choices.

In conclusion, while some individuals with obesity may appear metabolically healthy for a time, it is important to recognize that obesity remains a significant long-term health risk. All individuals with obesity, regardless of their immediate metabolic status, should receive appropriate and ongoing care that focuses on overall health and wellbeing rather than just weight loss. Even those who are temporarily considered healthy still face a significant risk of metabolic decline, emphasizing the need for ongoing and effective care. This requires a holistic approach that goes beyond just eating habits and physical activity to also include alcohol consumption and overall health management. This approach is essential not only to reduce the prevalence of obesity-related complications such as diabetes and hypertension but also to support the long-term well-being and quality of life for individuals living with obesity.

Data Availability

Due to ethical restrictions approved by the ethics committee of each institution (Universidade Federal de Minas Gerais, Universidade de São Paulo, Universidade Federal do Espírito Santo, Universidade Federal do Rio Grande do Sul, Universidade Federal da Bahia e Fundação Oswaldo Cruz) and by the Publications Committee of ELSA-Brasil (publiELSA), the data used in this study can be made available for research proposals by a request to ELSA's Datacenter (rb.sgrfu@asleacitsitatse) and to the ELSA's Publications Committee. Additional information can be obtained from the ELSA Coordinator from the Research Center of Espírito Santo (jose.mill@gmail.com).

Funding Statement

This research was funded by the Brazilian Ministry of Health (DECIT—Department of Science and Technology) and Ministry of Science and Technology (FINEP—Research Funding Agency and CNPq—National Council for Scientific and Technological Development—process numbers 01 06 0010.00 RS, 01 06 0212.00 BA, 01 06 0300.00 ES, 01 06 0278.00 MG, 01 06 0115.00 SP, 01 06 0071.00 RJ). These sources had no role in study design or publication.

References

  • 1.Kouvari M, M D’Cunha N, Tsiampalis T, Zec M, Sergi D, Travica N, et al. Metabolically healthy overweight and obesity, transition to metabolically unhealthy status and cognitive function: results from the framingham offspring study. Nutrients. 2023;15(5):1289. doi: 10.3390/nu15051289 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Netto AM, Kashiwagi NM, Minanni CA, Santos RD, Cesena FY. Adiposity, hepatic steatosis, and metabolic health transitions in people with obesity: Influences of age and sex. Nutr Metab Cardiovasc Dis 2023. Jun 1; 33(6):1149–57. [DOI] [PubMed] [Google Scholar]
  • 3.Araujo CFS, Mello JV de C, Duque AP, Nogueira I de CS, Mediano MFF, Rodrigues Junior LF, et al. Lack of association between metabolic phenotype and food consumption by degree of food processing: results from the Study of Workers’ Health (ESAT). Nutr Hosp. 2023. Feb 15; 40(1):119–27. [DOI] [PubMed] [Google Scholar]
  • 4.Zhang X, Zhu J, Kim JH, Sumerlin TS, Feng Q, Yu J. Metabolic health and adiposity transitions and risks of type 2 diabetes and cardiovascular diseases: a systematic review and meta-analysis. Diabetol Metab Syndr. 2023. Mar 28;15:60. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Palatini P, Saladini F, Mos L, Vriz O, Ermolao A, Battista F, et al. Healthy overweight and obesity in the young: Prevalence and risk of major adverse cardiovascular events. Nutr Metab Cardiovasc Dis 2024. Mar 1;34(3):783–91. [DOI] [PubMed] [Google Scholar]
  • 6.Camhi SM, Must A, Gona PN, Hankinson A, Odegaard A, Reis J, et al. Duration and stability of metabolically healthy obesity over 30 years. Int J Obes (Lond). 2019. Sep;43(9):1803–10. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Iacobini C, Pugliese G, BlasettiFantauzzi C, Federici M, Menini S. Metabolically healthy versus metabolically unhealthy obesity. Metabolism. 2019. Mar 1;92:51–60. [DOI] [PubMed] [Google Scholar]
  • 8.Hamer M, Bell JA, Sabia S, Batty GD, Kivimäki M. Stability of metabolically healthy obesity over 8 years: the English Longitudinal Study of Ageing. Eur J Endocrinol. 2015;173(5):703–8. doi: 10.1530/EJE-15-0449 [DOI] [PubMed] [Google Scholar]
  • 9.Wildman RP, Muntner P, Reynolds K, McGinn AP, Rajpathak S, Wylie-Rosett J, et al. The obese without cardiometabolic risk factor clustering and the normal weight with cardiometabolic risk factor clustering: prevalence and correlates of 2 phenotypes among the US population (NHANES 1999-2004). Arch Intern Med. 2008;168(15):1617–24. doi: 10.1001/archinte.168.15.1617 [DOI] [PubMed] [Google Scholar]
  • 10.Wang SH, Chung PS, Lin YP, Tsai KZ, Lin SC, Fan CH, et al. Metabolically healthy obesity and physical fitness in military males in the CHIEF study. Sci Rep. 2021. Apr 27;11:9088. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Cui H, Tian F, Chen Y, Ma X. Association between metabolically healthy status and risk of gastrointestinal cancer. Cancer Res Treat. 2024;56(1):238–46. doi: 10.4143/crt.2023.539 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Gao M, Lv J, Yu C, Guo Y, Bian Z, Yang R, et al. Metabolically healthy obesity, transition to unhealthy metabolic status, and vascular disease in Chinese adults: A cohort study. PLoS Med. 2020;17(10):e1003351. doi: 10.1371/journal.pmed.1003351 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Khalili S, Safavi-Naini SAA, Zarand P, Masoumi S, Farsi Y, Hosseinpanah F, et al. Metabolic health’s central role in chronic kidney disease progression: a 20-year study of obesity-metabolic phenotype transitions Sci Rep 2024. Mar 4;14:5244. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Canhada SL, Vigo Á, Luft VC, Levy RB, Alvim Matos SM, Del Carmen Molina M, et al. Ultra-Processed Food Consumption and Increased Risk of Metabolic Syndrome in Adults: The ELSA-Brasil. Diabetes Care. 2023;46(2):369–76. doi: 10.2337/dc22-1505 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Schmidt MI, Duncan BB, Mill JG, Lotufo PA, Chor D, Barreto SM, et al. Cohort Profile: Longitudinal Study of Adult Health (ELSA-Brasil). Int J Epidemiol. 2015;44(1):68–75. doi: 10.1093/ije/dyu027 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Quintino CR Obesidade, saúde metabólica e sua associação com a espessura íntima-média carotídea e calcificação coronariana. Universidade de São Paulo; 2019. [cited 2024 Mar 6]. http://www.teses.usp.br/teses/disponiveis/5/5169/tde-20032019-153038/. [Google Scholar]
  • 17.Lohman TJ, Roache AF, Martorell R. Anthropometric Standardization Reference Manual. In: Medicine & Science in Sports & Exercise [Internet]. 1992. [cited 2024 Mar 6]. p. 952. Available from: http://journals.lww.com/00005768-199208000-00020 [Google Scholar]
  • 18.Obesity: preventing and managing the global epidemic. Report of a WHO consultation. World Health Organ Tech Rep Ser. 2000;894:i–xii, 1–253. [PubMed] [Google Scholar]
  • 19.Fedeli LG, Vidigal PG, Leite CM, Castilhos CD, Pimentel RA, Maniero VC, et al. Logistics of collection and transportation of biological samples and the organization of the central laboratory in the ELSA-Brasil. Rev Saude Publica. 2013;47 Suppl 2:63–71. doi: 10.1590/s0034-8910.2013047003807 [DOI] [PubMed] [Google Scholar]
  • 20.Molina MDCB, Benseñor IM, Cardoso L de O, Velasquez-Melendez G, Drehmer M, Pereira TSS, et al. Reproducibility and relative validity of the Food Frequency Questionnaire used in the ELSA-Brasil. Cad Saude Publica. 2013;29(2):379–89. doi: 10.1590/s0102-311x2013000200024 [DOI] [PubMed] [Google Scholar]
  • 21.Mannato LW, Pereira TSS, Velasquez-Melendez G, Cardoso LO, Benseñor IM, Molina M CB. Comparison of a short version of the Food Frequency Questionnaire with its long version - a cross-sectional analysis in the Brazilian Longitudinal Study of Adult Health (ELSA-Brasil). Sao Paulo Med J. 2015;133:414–20. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Monteiro CA, Cannon G, Levy R, Moubarac JC, Jaime P, Martins AP, et al. NOVA. The star shines bright. World Nutrition 2016. Jan 7;7(1–3):28–38. [Google Scholar]
  • 23.Matsudo S, Araújo T, Matsudo V, Andrade D, Andrade E, Oliveira LC, et al. Questionário Internacional De Atividade Física (ipaq): estupo de validade e reprodutibilidade no Brasil. Rev. Bras. Ativ. Fis. Saúde 2001;6(2):5–18. [Google Scholar]
  • 24.Silva RC, Diniz MFHS, Alvim S, Vidigal PG, Fedeli LMG, Barreto SM. Atividade Física e Perfil Lipídico no Estudo Longitudinal de Saúde do Adulto (ELSA-Brasil). Arq Bras Cardiol. 2016. Jun 23;107:10–9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.WHO WHO. Global recommendations on physical activity for health [Internet]. 2010. [cited 2024 Jun 9]. Available from: https://www.who.int/publications-detail-redirect/9789241599979 [PubMed] [Google Scholar]
  • 26.Singh G, MacDorman M. Advance report of final mortality statistics, 1994. Monthly Vital Statistics Report. 1996;45(3). [Google Scholar]
  • 27.Song Z, Gao M, Lv J, Yu C, Guo Y, Bian Z, et al. Metabolically healthy obesity, transition to unhealthy phenotypes, and type 2 diabetes in 0.5 million Chinese adults: the China Kadoorie Biobank. Eur J Endocrinol. 2021;186(2):233–44. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Mathis BJ, Tanaka K, Hiramatsu Y. Factors of obesity and metabolically healthy obesity in Asia. Medicina (Kaunas). 2022;58(9):1271. doi: 10.3390/medicina58091271 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Chen F, Shi Y, Yu M, Hu Y, Li T, Cheng Y, et al. Joint effect of BMI and metabolic status on mortality among adults: a population-based longitudinal study in the United States. Sci Rep 2024. Feb 2;14:2775. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Hernández-Rubio A, Sanvisens A, Bolao F, Cachón-Suárez I, Garcia-Martín C, Short A, et al. Prevalence and associations of metabolic syndrome in patients with alcohol use disorder. Sci Rep. 2022. Feb 16;12:2625. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Mitkin NA, Unguryanu TN, Malyutina S, Kudryavtsev AV. Association between alcohol consumption and body composition in Russian adults and patients treated for alcohol-related disorders: the know your heart cross-sectional study. Int J Environ Res Public Health. 2023. Feb 7;20(4):2905. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Lin Y, Ying Y-Y, Li S-X, Wang S-J, Gong Q-H, Li H. Association between alcohol consumption and metabolic syndrome among Chinese adults. Public Health Nutr. 2021;24(14):4582–90. doi: 10.1017/S1368980020004449 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Wang W, Wei B, Song Y, Guo H, Zhang X, Wang X et al. Metabolically healthy obesity and unhealthy normal weight rural adults in Xinjiang: prevalence and the associated factors. BMC Public Health. 2021. Oct 26;21:1940. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Jahromi MK, Ebadinejad A, Barzin M, Mahdavi M, Niroomand M, Khalili D, et al. Association of cumulative excess weight and waist circumference exposure with transition from metabolically healthy obesity to metabolically unhealthy. Nutr Metab Cardiovasc Dis 2022. Nov 1;32(11):2544–52. [DOI] [PubMed] [Google Scholar]
  • 35.González-Palacios S, Oncina-Cánovas A, García-de-la-Hera M, Martínez-González MÁ, Salas-Salvadó J, Corella D, et al. Increased ultra-processed food consumption is associated with worsening of cardiometabolic risk factors in adults with metabolic syndrome: Longitudinal analysis from a randomized trial. Atherosclerosis. 2023. Jul 1;377:12–23. [DOI] [PubMed] [Google Scholar]
  • 36.IBGE. Instituto Brasileiro de Geografia e Estatística. IBGE | Biblioteca | Detalhes | Pesquisa de orçamentos familiares: 2017-2018: análise do consumo alimentar pessoal no Brasil/ IBGE, Coordenação de Trabalho e Rendimento. 2020. [cited 2024 Apr 17]. Available from: https://biblioteca.ibge.gov.br/index.php/biblioteca-catalogo?view=detalhes&id=2101742 [Google Scholar]
PLOS Glob Public Health. doi: 10.1371/journal.pgph.0004325.r002

Decision Letter 0

Vanessa Bezerra

14 Jan 2025

PGPH-D-24-02621

From Healthy to Unhealthy Obesity: A Longitudinal Study of Adults in ELSA-Brasil

PLOS Global Public Health

Dear Dr. Faria,

Thank you for submitting your manuscript to PLOS Global Public Health. After careful consideration, we feel that it has merit but does not fully meet PLOS Global Public Health’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please submit your revised manuscript by Feb 13 2025 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at globalpubhealth@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pgph/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

We look forward to receiving your revised manuscript.

Kind regards,

Vanessa Moraes Bezerra

Academic Editor

PLOS Global Public Health

Journal Requirements:

1. Please provide separate figure files in .tif or .eps format.

For more information about figure files please see our guidelines:

https://journals.plos.org/globalpublichealth/s/figures 

https://journals.plos.org/globalpublichealth/s/figures#loc-file-requirements

2. In the online submission form, you indicated that "Data described in the manuscript, code book, and analytic code will be made available upon reasonable request.". 

All PLOS journals now require all data underlying the findings described in their manuscript to be freely available to other researchers, either 

a. In a public repository, 

b. Within the manuscript itself, or 

c. Uploaded as supplementary information.

This policy applies to all data except where public deposition would breach compliance with the protocol approved by your research ethics board. If your data cannot be made publicly available for ethical or legal reasons (e.g., public availability would compromise patient privacy), please explain your reasons by return email and your exemption request will be escalated to the editor for approval. Your exemption request will be handled independently and will not hold up the peer review process, but will need to be resolved should your manuscript be accepted for publication. One of the Editorial team will then be in touch if there are any issues.

3. Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice.

Additional Editor Comments (if provided):

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Does this manuscript meet PLOS Global Public Health’s publication criteria ? Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe methodologically and ethically rigorous research with conclusions that are appropriately drawn based on the data presented.

Reviewer #1: Yes

Reviewer #2: Yes

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

Reviewer #2: Yes

**********

3. Have the authors made all data underlying the findings in their manuscript fully available (please refer to the Data Availability Statement at the start of the manuscript PDF file)?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception. The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS Global Public Health does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: e MHO as a transitory state, which could be revised to reflect the limitations of current knowledge on the subject.

Regarding the discussion, I recommend including reflections on the challenges of caring for individuals with obesity, highlighting the importance of overcoming practices focused exclusively on weight loss and the pathologization of larger bodies. Considering obesity as a chronic and recurrent condition, it is crucial to emphasize empathetic and comprehensive care strategies that promote healthy lifestyles and embrace individual experiences. These adjustments could significantly contribute to enhancing the relevance and applicability of the results, both in the clinical context and in the development of more inclusive health policies.

Introduction

In the second paragraph of the introduction, the current wording suggests that the authors already assert the nonexistence of metabolically healthy obesity (MHO). I recommend revising this section to provide a balanced discussion of the evidence both supporting and opposing this condition (lines 48-62, page 7).

Additionally, the phrasing of the hypothesis implies that the group assumes MHO to be a transitional state. Given the current limitations in knowledge on this topic, I suggest rethinking how this hypothesis is presented to better reflect the uncertainties and nuances still under investigation.

Methods

What is the reason for not using data from the second wave to track weight variation over the years?

Overall, the methods are well-described and meet the requirements of the proposed analyses, but including this information could enhance the understanding of the approach adopted.

Results

I would like to understand why the variables associated with changes in body weight over the years were not presented. Were these data analyzed? If so, did they have a relationship with MHO?

I believe this analysis would be crucial to better understand the relationship between obesity diagnosed by BMI and the observed metabolic changes.

Discussion

In line 325, I suggest paying attention to the use of acronyms and recommend replacing them with full terms for better clarity.

Overall, the discussion is well-grounded and incorporates important references on the topic. However, it would be valuable to include reflections on the challenges of caring for people with obesity and the experience of living with a chronic and recurrent condition. It is urgent to construct new narratives that help move beyond practices focused exclusively on weight loss and the pathologization of larger bodies.

I invite the authors to reflect on the importance of care strategies that do not reinforce blame and, instead, promote the development of more empathetic and inclusive practices that support the maintenance of a healthy life regardless of weight loss. Metabolically healthy obesity is a complex issue that can contribute to the development of broader and health-centered indicators rather than relying solely on weight or the exclusive use of BMI as a monitoring parameter.

Conclusion Revision

The evidence found highlights alcohol consumption and increased waist circumference as risk factors for metabolic transition. This underscores the need to promote healthy habits as central components of obesity care.

Considering obesity as a chronic and recurrent condition, we emphasize that care must go beyond an exclusive focus on weight loss. It is essential to incorporate balanced eating, regular physical activity, moderation in alcohol consumption, stress management, and other aspects. These measures can contribute to preventing metabolic changes and promoting overall well-being.

Reviewer #2: Thank you for the opportunity to review this paper. This article is relevant to health promotion and prevention of obesity-related complications.

The methodology used in this study is suitable for answering the research objectives. There are issues that could be best described:

Methods

Line 112: "Food intake was analyzed longitudinally (dynamic model),...".

The authors need to better explain or reference the model used to estimate food intake

Line 116 - 119: "The International Physical Activity Questionnaire (IPAQ) long version, validated for Brazil by Matsudo et al. (23), was applied. Physical activity was recorded in minutes per week and subdivided into low, moderate, and high categories, according to the World Health Organization (24)."

It is not clear how the physical activity variable was calculated and categorized. What are the cutoff points? It is necessary to justify the choice of the term low, moderate, and high.

The studies, for the most part, classify whether the individual is inactive, insufficiently active or active

Results

Age was divided into quartiles. Report the cutoff points for each category

In the tables, inform in the legend what O1 and O3 of the variables mean: % of grams of MPF O1 and O3, % of grams of PF O1 and O3 and % of grams of UPF O1 and O3

Line 244-246: "Also, the final regression was tested using the follow up duration as a potential confounder and it yielded extremely similar results, demonstration no significant effect on the risk factors identified or their measures of association."

The authors need to explain why they considered follow-up time as a confounding factor. By considering follow-up time in the analysis, the measure of occurrence and association would change.

Discussion

It would be easier for the reader if the authors, when comparing with the literature, informed the study population and location of the cited reference. For example:

Line 261-262: "The work of Palatini and colleagues indicated that the MHO state is an unstable condition, as after 7.5 years of follow up, 59.3% of MHO individuals transitioned to an unhealthy status (5)."

Line 286-287: "Among these patients, 86.9% were individuals with 287 obesity, 27.7% determined as having diabetes, and 78.2% had elevated fasting glucose levels."

Line 319-322: "Another study conducted a 30-year follow-up to observe the 320 transition of metabolic status and stated that women move in and out of the MHO classification over the years, while men do not; after transitioning from MHO to MUO status, they generally remain in the unhealthy state(6)."

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean? ). If published, this will include your full peer review and any attached files.

Do you want your identity to be public for this peer review? If you choose “no”, your identity will remain anonymous but your review may still be made public.

For information about this choice, including consent withdrawal, please see our Privacy Policy .

Reviewer #1: Yes:  Poliana Cardoso Martins

Reviewer #2: No

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

Attachment

Submitted filename: PLOS Global Public Health_OBMS.pdf

pgph.0004325.s001.pdf (49KB, pdf)
PLOS Glob Public Health. doi: 10.1371/journal.pgph.0004325.r004

Decision Letter 1

Julia Robinson

4 Apr 2025

From Healthy to Unhealthy Obesity: A Longitudinal Study of Adults in ELSA-Brasil

PGPH-D-24-02621R1

Dear Prof. Faria,

We are pleased to inform you that your manuscript 'From Healthy to Unhealthy Obesity: A Longitudinal Study of Adults in ELSA-Brasil' has been provisionally accepted for publication in PLOS Global Public Health.

Before your manuscript can be formally accepted you will need to complete some formatting changes, which you will receive in a follow up email. A member of our team will be in touch with a set of requests.

Please note that your manuscript will not be scheduled for publication until you have made the required changes, so a swift response is appreciated.

IMPORTANT: The editorial review process is now complete. PLOS will only permit corrections to spelling, formatting or significant scientific errors from this point onwards. Requests for major changes, or any which affect the scientific understanding of your work, will cause delays to the publication date of your manuscript.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they'll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact globalpubhealth@plos.org.

Thank you again for supporting Open Access publishing; we are looking forward to publishing your work in PLOS Global Public Health.

Best regards,

Julia Robinson

Executive Editor

PLOS Global Public Health

***********************************************************

Reviewer Comments (if any, and for reference):

Reviewer's Responses to Questions

Comments to the Author

1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.

Reviewer #2: All comments have been addressed

**********

2. Does this manuscript meet PLOS Global Public Health’s publication criteria ? Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe methodologically and ethically rigorous research with conclusions that are appropriately drawn based on the data presented.

Reviewer #2: Yes

**********

3. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #2: Yes

**********

4. Have the authors made all data underlying the findings in their manuscript fully available (please refer to the Data Availability Statement at the start of the manuscript PDF file)?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception. The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #2: Yes

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS Global Public Health does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #2: Yes

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #2: (No Response)

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean? ). If published, this will include your full peer review and any attached files.

Do you want your identity to be public for this peer review? If you choose “no”, your identity will remain anonymous but your review may still be made public.

For information about this choice, including consent withdrawal, please see our Privacy Policy .

Reviewer #2: No

**********

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    Attachment

    Submitted filename: PLOS Global Public Health_OBMS.pdf

    pgph.0004325.s001.pdf (49KB, pdf)
    Attachment

    Submitted filename: RESPONSE TO THE REVIEWERS - MHO - PLoS ONE 04022025.docx

    pgph.0004325.s003.docx (24KB, docx)

    Data Availability Statement

    Due to ethical restrictions approved by the ethics committee of each institution (Universidade Federal de Minas Gerais, Universidade de São Paulo, Universidade Federal do Espírito Santo, Universidade Federal do Rio Grande do Sul, Universidade Federal da Bahia e Fundação Oswaldo Cruz) and by the Publications Committee of ELSA-Brasil (publiELSA), the data used in this study can be made available for research proposals by a request to ELSA's Datacenter (rb.sgrfu@asleacitsitatse) and to the ELSA's Publications Committee. Additional information can be obtained from the ELSA Coordinator from the Research Center of Espírito Santo (jose.mill@gmail.com).


    Articles from PLOS Global Public Health are provided here courtesy of PLOS

    RESOURCES